64800 Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices 

ATP; specifically, Respondent (1) 

falsified the units and labels of the 

axes, (2) falsified the labels of the 

curves, and (3) vertically inverted 

the curves 

d. falsified Figure 5E in the JBC 2006 

manuscript, representing a 

competition experiment for the 

release of tagged GTPgS bound to 

TGase 3 with the addition of 

cystamine, when the actual 

experiment was a competition 

experiment with the addition of 

untagged nucleotides. 

Dr. Ahvazi has entered into a 

Voluntary Settlement Agreement 

(Agreement) and has voluntarily agreed 

for a period of two (2) years, beginning 

on October 7, 2014: 

(1) To have his U.S. Public Health 

Service (PHS) research supervised and 

to notify any employer(s)/institution(s) 

at which he may participate in PHS 

funded projects of the terms of his 

supervision; Respondent agrees that 

prior to the submission of an 

application for PHS support for a 

research project on which the 

Respondent’s participation is proposed 

and prior to Respondent’s participation 

in any capacity on PHS-supported 

research, Respondent shall ensure that a 

plan for supervision of Respondent’s 

duties is submitted to ORI for approval; 

the supervision plan must be designed 

to ensure the scientific integrity of 

Respondent’s research; Respondent 

agrees that he shall not participate in 

any PHS-supported research until such 

a supervision plan is submitted to and 

approved by ORI; Respondent agrees to 

maintain responsibility for compliance 

with the agreed upon supervision plan; 

(2) that any institution employing him 

to work on PHS-supported projects shall 

submit, in conjunction with each 

application for PHS funds, or report, 

manuscript, or abstract involving PHSsupported research in which 

Respondent is involved, a certification 

to ORI that the data provided by 

Respondent are based on actual 

experiments or are otherwise 

legitimately derived and that the data, 

procedures, and methodology are 

accurately reported in the application, 

report, manuscript, or abstract; and 

(3) to exclude himself voluntarily 

from serving in any advisory capacity to 

PHS including, but not limited to, 

service on any PHS advisory committee, 

board, and/or peer review committee, or 

as a consultant. 

FOR FURTHER INFORMATION CONTACT: 

Acting Director, Office of Research 

Integrity, 1101 Wootton Parkway, Suite 

750, Rockville, MD 20852, (240) 453– 

8200. 

Donald Wright, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2014–25887 Filed 10–30–14; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Intent To Award Ebola 

Response Outbreak Funding to 

Eligible Ministries of Health and Their 

Bona Fide Agents 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice provides public 

announcement of CDC’s intent to award 

Ebola appropriations to select Ministries 

of Health and their bona fide agents for 

response to the Ebola outbreak funding. 

This award was proposed in Fiscal Year 

(FY) 2015 under funding opportunity 

announcement GH14–1418, ‘‘Protecting 

and Strengthening Public Health 

Impact, Systems, Capacity, and 

Security.’’ 

This notice replaces the Notice of 

Intent to award Ebola Response 

outbreak funding to eligible Ministries 

of Health and their bona fide agents 

which was published on October 22, 

2014 (79 FR 63126, October 22, 2014). 

CDC is correcting the application date, 

award dates, amount of funding 

available, and one of the points of 

contact. 

Catalogue of Federal Domestic Assistance 

Number (CFDA): 93.318. 

Authority: Public Health Service 301(a) 

and 307 as amended [42 U.S.C 241 and 242l]. 

Multiple awards may be awarded to 

grantees totaling $300,000 to $1,500,000 

per award for the Ebola response 

outbreak. 

Funding is appropriated under the 

Continuing Appropriations Resolution, 

2015, Public Law 113–164, 128 Stat. 

1867 (2014). 

DATES: Anticipated award date is 12/11/ 

2014. 

Application Due Date: 12/1/2014. 

Project Number is CDC–RFA–GH14– 

1418. 

ADDRESSES: CDC has waived the 

Grants.gov electronic submission 

process for this requirement. Recipients 

are hereby authorized to submit a paper 

copy application for (CDC–RFA–GH14– 

1418) via Express Mail (i.e. FedEx, UPS, 

or DHL) and send the application via 

email. Mailed applications must be 

address to Dionne Bounds, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone (770) 488–2082, or email at 

DBounds@cdc.gov. The application 

must include a detailed line-item budget 

and justification to support the Ebola 

activities from December 11, 2014 to 

September 29, 2015. Please download 

the following to complete the 

application package: http://

apply07.grants.gov/apply/forms/

sample/SF424_2_1-V2.1.pdf— 

Application Package; http://

www.cdc.gov/od/pgo/funding/docs/

CertificationsForm.pdf—Certifications; 

http://www.cdc.gov/od/pgo/funding/

grants/Budget_Preparation_Guidelines_

8-2-12.docx—CDC–PGO Budget 

Guidelines; http://apply07.grants.gov/

apply/forms/sample/SF424A-V1.0.pdf— 

SF–424A Budget Information. 

All applications must be submitted to 

and received by the Grants Management 

Officer (GMO) no later than 11:59 p.m. 

EST on December 1, 2014 and please 

provide the GMO a PDF version of the 

application by email to the following 

email address: ogsghebolaresponse@

cdc.gov subject line: CDC–RFA–GH14– 

1418. 

Applicants will be provided with the 

Funding Opportunity Announcement 

(FOA) and additional application 

submission guidance via email 

notification. Applicants may contact the 

POCs listed with questions regarding 

the application process. 

FOR FURTHER INFORMATION CONTACT: 

For programmatic or technical 

assistance: Kawi Mailutha, Project 

Officer, Department of Health and 

Human Services, Centers for Disease 

Control and Prevention, 1600 Clifton 

Rd. MS E–29, Atlanta, GA 30333, 

Telephone: 404–639–8093, E-Mail: 

KMailutha@cdc.gov. 

For financial, awards management, or 

budget assistance: Dionne Bounds, 

Grants Management Officer, Centers for 

Disease Control and Prevention, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone (770) 488–2082, Email: 

DBounds@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

purpose of this notice is to solicit 

applications from eligible Ministries of 

Health and their bona fide agents to 

quickly arrest the spread of the Ebola 

virus in West Africa and contain the 

disease as quickly as possible. The 

funding will support the impacted 

countries and the surrounding countries 

to combat this health crisis. This 

funding will target the following 

countries: Liberia, Sierra Leone, Guinea, 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 211 / Friday, October 31, 2014 / Notices 64801 

Mauritania, Mali, Senegal, Guinea 

Bissau, Ghana, Gambia, Cote d’Ivoire, 

Togo, Benin, Burkina Faso, Niger and 

Nigeria to support the responses of the 

CDC to the outbreak of Ebola virus in 

West Africa. This funding will enable 

the U.S. to provide unified mobilization 

to address a crisis of this magnitude. 

CDC will continue to build partnerships 

and strengthen existing projects to 

respond to Ebola. CDC and its partners 

will help to address the need for 

surveillance, detection, coordination, 

response, and increase eligible 

governments’ capacity to respond to the 

Ebola outbreak. 

Award Information 

Type of Award: Cooperative 

Agreement. 

Approximate Total Current Fiscal 

Year Funding: $10,000,000. 

Anticipated Number of Awards: 

Multiple. 

Fiscal Year Funds: 2015. 

Anticipated Award Date: December 

11, 2014. 

Application Selection Process: 

Funding will be awarded to applicant 

based on results from the technical 

review recommendation. 

Dated: October 28, 2014. 

Ron A. Otten, 

Acting Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2014–25920 Filed 10–28–14; 11:15 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1615–FN] 

Medicare Program; Approval of 

Request for an Exception to the 

Prohibition on Expansion of Facility 

Capacity Under the Hospital 

Ownership and Rural Provider 

Exceptions to the Physician SelfReferral Prohibition 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Final notice. 

SUMMARY: This final notice announces 

our decision to approve the request from 

Lake Pointe Medical Center for an 

exception to the prohibition against 

expansion of facility capacity. 

DATES: Effective Date: This notice is 

effective on October 31, 2014. 

FOR FURTHER INFORMATION CONTACT: 

Patricia Taft, (410) 786–4561 or Teresa 

Walden, (410) 786–3755. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Unless the requirements of an 

applicable exception are satisfied, 

section 1877 of the Social Security Act 

(the Act), also known as the physician 

self-referral law—(1) prohibits a 

physician from making referrals for 

certain ‘‘designated health services’’ 

(DHS) payable by Medicare to an entity 

with which he or she (or an immediate 

family member) has a financial 

relationship (ownership or 

compensation); and (2) prohibits the 

entity from filing claims with Medicare 

(or billing any individual, third party 

payer, or other entity) for those DHS 

furnished as a result of a prohibited 

referral. Section 1877(d)(3) of the Act 

provides an exception, known as the 

‘‘whole hospital exception,’’ for 

physician ownership or investment 

interests held in a hospital located 

outside of Puerto Rico, provided that the 

referring physician is authorized to 

perform services at the hospital and the 

ownership or investment interest is in 

the hospital itself (and not merely in a 

subdivision of the hospital). Section 

1877(d)(2) of the Act provides an 

exception for physician ownership or 

investment interests in rural providers 

(the ‘‘rural provider exception’’). In 

order for an entity to qualify for the 

rural provider exception, the DHS must 

be furnished in a rural area (as defined 

in section 1886(d)(2) of the Act) and 

substantially all the DHS furnished by 

the entity must be furnished to 

individuals residing in a rural area. 

Section 6001(a)(3) of the Patient 

Protection and Affordable Care Act 

(Pub. L. 111–148) as amended by the 

Health Care and Education 

Reconciliation Act of 2010 (Pub. L. 111– 

152) (hereafter referred to together as 

‘‘the Affordable Care Act’’) amended the 

whole hospital and rural provider 

exceptions to the physician self-referral 

prohibition to impose additional 

restrictions on physician ownership and 

investment in hospitals and rural 

providers. Since March 23, 2010, a 

physician-owned hospital that seeks to 

avail itself of either exception is 

prohibited from expanding facility 

capacity unless it qualifies as an 

‘‘applicable hospital’’ or ‘‘high Medicaid 

facility’’ (as defined in sections 

1877(i)(3)(E), (F) of the Act and 42 CFR 

411.362(c)(2), (3) of our regulations) and 

has been granted an exception to the 

facility expansion prohibition by the 

Secretary. Section 1877(i)(3)(A)(ii) of the 

Act provides that individuals and 

entities in the community in which the 

provider requesting the exception is 

located must have an opportunity to 

provide input with respect to the 

provider’s application for the exception. 

Section 1877(i)(3)(H) of the Act states 

that the Secretary shall publish in the 

Federal Register the final decision with 

respect to an application for an 

exception to the prohibition against 

facility expansion not later than 60 days 

after receiving a complete application. 

For further information on the 

physician-owned hospital expansion 

exception process, visit our Web site at: 

http://www.cms.gov/Medicare/Fraudand-Abuse/PhysicianSelfReferral/

Physician_Owned_Hospitals.html. 

II. Exception Approval Process 

On November 30, 2011, we published 

a final rule in the Federal Register (76 

FR 74122, 74517 through 74525) that, 

among other things, finalized 

§ 411.362(c), which specified the 

process for submitting, commenting on, 

and reviewing a request for an exception 

to the prohibition on expansion of 

facility capacity. We specified that prior 

to our review of the request, we will 

solicit community input on the request 

for an exception by publishing a notice 

of the request in the Federal Register 

(see § 411.362(c)(5)). We also stated that 

individuals and entities in the hospital’s 

community have 30 days to submit 

comments on the request. Community 

input must take the form of written 

comments and may include 

documentation demonstrating that the 

physician-owned hospital requesting 

the exception does or does not qualify 

as an ‘‘applicable hospital’’ or ‘‘high 

Medicaid facility,’’ as such terms are 

defined in § 411.362(c)(2) and (3). 

Although we gave examples of 

community input, such as 

documentation demonstrating that the 

hospital does not satisfy one or more of 

the data criteria or that the hospital 

discriminates against beneficiaries of 

Federal health care programs, we noted 

that these were examples only and that 

we would not restrict the type of 

community input that may be submitted 

(76 FR 74522). If we receive timely 

comments from the community, we will 

notify the hospital, and the hospital has 

30 days after such notice to submit a 

rebuttal statement (§ 411.362(c)(5)(ii)). 

A request for an exception to the 

facility expansion prohibition is 

considered complete and ready for CMS 

review if no comments from the 

community are received by the close of 

the 30-day comment period. If we 

receive timely comments from the 

community, we consider the request to 

be complete 30 days after the hospital 

is notified of the comments. If we grant 

the request for an exception to the 

prohibition on expansion of facility 


asabaliauskas on DSK5VPTVN1PROD with NOTICES